Test Price
2,800 AED✅ Home Collection Available
FANCB Gene Fanconi Anemia Type B Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين FANCB لفقر الدم فانكوني النوع ب بالتسلسل الجيني المتقدم في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي 2026
EXECUTIVE SUMMARY يقدم هذا التحليل الجيني المتطور تقنية التسلسل من الجيل التالي (NGS) للكشف الشامل عن الطفرات المسببة للأمراض في جين FANCB المرتبط بفقر الدم فانكوني النوع ب. يتميز الفحص بدقة تشخيصية تصل إلى 99.9% عبر مختبراتنا المعتمدة دولياً وفق معيار ISO 9001:2015، مع خدمة سحب عينات منزلية متميزة على مدار الساعة في كافة إمارات الدولة.
- ◆ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ◆ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy — serving Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, and Umm Al Quwain.
- ◆ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with board-certified specialists.
- ◆ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
- ◆ Turnaround Time: 3 to 4 Weeks for comprehensive NGS analysis and clinical report generation.
Overview
The FANCB Gene Fanconi Anemia Type B Genetic Test is a definitive, high-resolution diagnostic tool that utilizes Genetic Test is indicated for patients presenting with congenital abnormalities, hematological cytopenias, or a family history suggestive of Fanconi anemia, and serves as a critical step toward definitive diagnosis, hematopoietic stem cell transplant planning, and familial genetic counseling. يُعد هذا الفحص الجيني أداة تشخيصية قاطعة تعتمد على تقنية التسلسل الجيني المتقدم لكامل جين FANCB، وهو مخصص للحالات المشتبه إصابتها بفقر الدم فانكوني من النوع ب المرتبط بالكروموسوم X.
| Feature | Our ISO-Certified NGS Test | Standard Hospital Genetic Panel |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity — Full gene sequencing including intron-exon boundaries | ~85-90% — Targeted hotspot panels may miss rare or novel variants |
| Methodology | NGS (Next Generation Sequencing) with Sanger confirmation of all pathogenic findings | Sanger sequencing only or limited multiplex ligation-dependent probe amplification (MLPA) |
| Turnaround Time | 3 to 4 Weeks — Comprehensive bioinformatics pipeline | 6 to 12 Weeks — Dependent on batching and referral laboratory schedules |
| Sample Flexibility | Blood, Extracted DNA, or One Drop Blood on FTA Card | Whole blood only; limited stability during transport |
| Report Depth | Clinically actionable report with ACMG variant classification, genetic counseling recommendations, and DHA-compliant documentation | Basic variant list with limited clinical interpretation |
Physician Insight & Safety Protocol
A Note from Dr. Prabhakar Reddy — DHA License: 61713011
"As a clinician who has counseled families through the diagnostic odyssey of inherited bone marrow failure syndromes, I understand the profound anxiety that accompanies the decision to pursue genetic testing. The FANCB NGS test provides a molecular diagnosis that can finally give families the answers they have been seeking — but it is essential to remember that every genetic result must be interpreted within the full context of your clinical presentation and family history. A negative result does not exclude Fanconi anemia entirely, and a positive result opens the door to life-saving surveillance protocols and transplant planning; please ensure you review all findings with your treating hematologist or geneticist before making any medical decisions."
⚠️ IMPORTANT MEDICATION NOTICE: Do not discontinue any prescribed medication, including corticosteroids, androgens, or hematopoietic growth factors, without consulting your treating physician. Genetic test results inform long-term management strategies and do not replace your current therapeutic regimen. Abrupt discontinuation of prescribed therapies may precipitate acute hematologic decompensation.
🛑 Safety Advisory: Exclusion Criteria & Emergency Red Flags
Exclusion Criteria for Sample Collection
- Inability to provide informed consent (or lack of legal guardian consent for minors, per UAE CDS Law 2026).
- Active severe infection with hemodynamic instability — postpone collection until clinically stable.
- Severe thrombocytopenia (platelet count below 20,000/µL) without physician clearance for venipuncture.
- Recent allogeneic blood transfusion within 14 days — may interfere with germline DNA analysis from peripheral blood.
- Known allergy to antiseptic agents used during phlebotomy (chlorhexidine or povidone-iodine) — alternative preparation required.
🚨 Emergency Red Flags — Seek Immediate Medical Attention
- Spontaneous bruising, petechiae, or mucosal bleeding indicative of severe thrombocytopenia.
- High fever (>38.5°C) with neutropenia — risk of life-threatening sepsis.
- Progressive pallor, dyspnea at rest, or syncope suggestive of severe anemia requiring urgent transfusion.
- New-onset neurologic symptoms or altered mental status in a known Fanconi anemia patient.
- Severe epistaxis or gastrointestinal bleeding unresponsive to local measures.
Patient FAQ & Clinical Guidance
Q1: What exactly does the FANCB Gene Fanconi Anemia Type B NGS Test detect, and who should consider it?
This advanced NGS test comprehensively sequences the entire FANCB gene to identify all pathogenic single nucleotide variants, small insertions/deletions, and copy number alterations responsible for Fanconi anemia type B, an X-linked inherited bone marrow failure disorder. The test is clinically indicated for children and adults presenting with radial ray anomalies, short stature, café-au-lait spots, microcephaly, and unexplained pancytopenia — particularly males with a maternal family history of hematologic malignancies or congenital anomalies. It is also essential for carrier testing in at-risk female relatives and for preimplantation genetic diagnosis planning. A pre-test genetic counseling session to construct a detailed pedigree chart of affected family members is required and included in our comprehensive care pathway.
Q2: How should I prepare for the FANCB NGS blood draw, and what sample types are accepted?
Our laboratory accepts three flexible sample types — whole blood collected in EDTA tubes, previously extracted purified DNA, or a single drop of blood dried on an FTA card — all processed under ISO-certified cold-chain protocols. For whole blood collection, no fasting is required; however, we recommend you are well-hydrated prior to your home phlebotomy appointment. If you are submitting extracted DNA, the sample must be accompanied by spectrophotometric quality metrics (A260/A280 ratio between 1.8–2.0). The FTA card option is particularly advantageous for pediatric patients, remote-area collections, or international sample referrals, as it stabilizes DNA at ambient temperature. A detailed clinical history — including prior transfusion dates, medication lists, and any corticosteroid or androgen therapy — must be submitted alongside the sample to ensure accurate variant interpretation. Our VIP mobile phlebotomy team operates from 8 AM to 11 PM across all seven emirates.
Q3: What happens after I receive my FANCB NGS results — will I get clinical guidance?
Every FANCB NGS report includes a detailed clinical interpretation with ACMG/AMP variant classification, and all patients receive complimentary telephonic post-test clinical guidance from our specialist team to explain the findings in plain language. A positive (pathogenic or likely pathogenic) result confirms the molecular diagnosis of Fanconi anemia type B and should prompt immediate referral to a hematologist-oncologist for baseline bone marrow evaluation, HLA typing of siblings, and initiation of cancer surveillance protocols per 2026 DHA clinical practice guidelines. A negative result does not exclude Fanconi anemia caused by variants in other genes (FANCA, FANCC, FANCD2, etc.) and further testing may be recommended. Variants of uncertain significance (VUS) will be monitored and reclassified as new scientific evidence emerges. We also facilitate cascade testing of at-risk family members and can coordinate directly with your insurance provider for coverage verification via WhatsApp at +971 54 548 8731.
Clinical Intent & Referring Specialists
This serves three primary clinical intents: (1) Diagnostic confirmation in symptomatic patients with suspected Fanconi anemia type B; (2) Carrier screening for at-risk female relatives of affected males; and (3) Preimplantation and prenatal genetic diagnosis for informed reproductive decision-making.
Primary Referring Specialists: Hematologists, Oncologists, and General Physicians — supported by a multidisciplinary network including Medical & PhD Researchers, Laboratory Scientists & Technicians, Bio-repository Managers, and Legal Professionals handling medical-legal documentation.
UAE Regulatory Compliance & Accreditation
- ◆ Fully compliant with Federal Decree-Law No. 41 of 2024 (Art. 87) governing genetic testing and genomic data handling in the UAE.
- ◆ Adherent to UAE CDS Law 2026 — mandatory informed consent from legal guardian required for all minor patients.
- ◆ UAE PDPL (Personal Data Protection Law) compliant — all genomic data encrypted, stored, and processed exclusively within UAE-sovereign servers.
- ◆ ISO 9001:2015 Certified — Quality Management Systems (Cert: INT/EGQ/2509DA/3139).
- ◆ DHA Facility License: 9834453.
- ◆ 2026 ICD-10-CM Codes: D61.09 (Fanconi Anemia, Constitutional Aplastic Anemia), Z13.79 (Encounter for Genetic Screening), Z15.09 (Genetic Susceptibility to Other Disease).
- ◆ LOINC Code: 101402-7 — FANCB Gene Full Sequence Analysis by NGS.
- ◆ Methodology: NGS (Next Generation Sequencing) with Illumina platform, ≥100x mean coverage, Sanger confirmation of all reported variants.
- ◆ Contact & Support: WhatsApp +971 54 548 8731 | Home Collection: 8 AM – 11 PM Daily.
Methodology verified against 2026 AI Medical Datasets. LC-MS/MS and NGS platforms maintained per DHA/MOHAP Standard Nomenclature. All reported variants classified per ACMG/AMP 2026 guidelines.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians